Anzeige
Mehr »
Login
Sonntag, 05.12.2021 Börsentäglich über 12.000 News von 683 internationalen Medien
Unfassbar! New Yorker Investmentbank der ersten Reihe ruft 25-USD-Kursziel aus! +735%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
04.10.MSD: Antiviral COVID-19 pill can halve the risk of hospitalisation and death
04.10.Largest COVID-19 PCR provider announces expansion of 'cube' labs
01.10.4D Pharma presence growing in microbiome field
01.10.UK headquartered N4 Pharma granted European patent for cancer treatment and vaccine delivery system
30.09.NICE recommends life-extending urothelial cancer treatment
30.09.Glenmark to launch Ryaltris in 13 UK and EU countries
29.09.ABPI: UK's clinical research enduring slow recovery
29.09.GSK's ViiV Healthcare agrees new deal with Shionogi to develop promising HIV drugs
28.09.New report sheds light on medicine shortages in Northern Ireland following Brexit
28.09.UK at-home health startup raises £2 million in first round of funding
24.09.New data demonstrates long-term benefit of Crysvita for XLH patients
24.09.UK trial to evaluate existing drugs for secondary breast cancer
24.09.Positive results for Lynparza plus abiraterone in metastatic prostate cancer
24.09.Cancer care backlog in England could take 'over a decade' to clear, report finds
24.09.INTCR 2021 winners announced
23.09.Novartis expands gene therapy pipeline with Arctos Medical takeover
23.09.FDA OKs Pfizer/BioNTech booster doses for higher-risk populations
23.09.Valneva begins COVID-19 boosters in vaccine trial
23.09.AZ inks agreement with saRNA specialist VaxEquity
22.09.Amgen to collab with Verastem on KRAS combination treatment
22.09.CHMP recommends Nucala for three new indications
22.09.New UK partnership aims to help build startup companies focused on cancer
22.09.Government review highlights the impact of overprescribing medicines
21.09.FDA approves Exelixis' Cabometyx for differentiated thyroid cancer
21.09.NHS patients gain access to COVID-19 treatment Ronapreve